Hormone Therapy News

When Olympic gold medalist and reality star Bruce Jenner came out as transgender in a high-profile television interview, a national audience was able to put a well-known face with a long-misunderstood gender identity.

Dose- and concentration-dependent decrease in average vocal pitch was found among women with higher levels of testosterone administration over 24 weeks, according to recent study findings published in The Journal of Clinical Endocrinology & Metabolism.

The risk for breast cancer associated with use of menopausal hormone therapy changes over time, according to an analysis of two Women’s Health Initiative clinical trials.

According to researchers, tamoxifen may have been overestimated previously as a microvascular thrombotic risk factor, with data suggesting that withholding the therapy for 2 weeks prior to breast reconstruction could potentially mitigate thrombotic risk.

In children without known risk factors for developing cancer, the use of growth hormone therapy appears to be safe and does not confer an increased risk for subsequent cancer, according to recent study findings published in The Journal of Clinical Endocrinology & Metabolism.

Ten weeks of therapy with a diazoxide choline controlled-release tablet appeared to help control hyperphagia and reduce antisocial behaviors associated with Prader-Willi syndrome, according to a press release from the drug’s developer, Essentialis, Inc.

In women treated with statins, hormone therapy appears to decrease the risk for death from any cause, according to research published in Menopause.

Melatonin could offer more and better quality sleep compared with earplugs and eye masks after exposure to environments with high levels of noise and light, according to research published in Critical Care.  

Hormone replacement therapy does not protect postmenopausal women against cardiovascular disease and may increase their risk for stroke and venous thromboembolic events, according to research published in the Cochrane Library.

Women in midlife experienced decreases in menopause-related symptoms and temporal high-frequency brain electrical activity with a noninvasive technology to calibrate neural oscillations, according to research published in Menopause.